Literature DB >> 9253120

Safety and efficiency of laparoscopic varicocelectomy in one hundred consecutive cases.

C E Iselin1, U Almagbaly, F Borst, S Rohner, F Schmidlin, A Campana, P Graber.   

Abstract

The purpose of this study is to report the safety and efficiency of laparoscopic varicocelectomy in 100 consecutive patients operated at a single teaching institution. There were three indications: (1) infertility associated with oligo-astheno-teratospermia (n = 52); (2) chronic dragging sensation of the left testicle (n = 42), and (3) incidental finding of a large varicocele in young adolescents (n = 6). In group 1, the postoperative pregnancy rate was 47% and sperm quantity, concentration and mobility were significantly increased. The efficiency in pain control and clinical outcome amounted to 80 and 100% in groups 2 and 3, respectively. Complications were few and minor. There was no intraperitoneal organ or major vessel injury. The mean length of hospital stay (0.9 days) and median total recovery time (5 days) were remarkably short. In conclusion, laparoscopic varicocelectomy is a safe procedure. It is as efficient as open spermatic vein ligation, and provides the patient with a short hospital stay and quick full recovery.

Entities:  

Mesh:

Year:  1997        PMID: 9253120     DOI: 10.1159/000282986

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive procedures.

Authors:  S Beutner; M May; B Hoschke; C Helke; M Lein; J Roigas; M Johannsen
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

2.  Effects of micronised purified flavonoid fraction on pain, semen analysis and scrotal color Doppler parameters in patients with painful varicocele; results of a randomized placebo-controlled study.

Authors:  Haluk Söylemez; Süleyman Kiliç; Murat Atar; Necmettin Penbegül; Ahmet Ali Sancaktutar; Yaşar Bozkurt
Journal:  Int Urol Nephrol       Date:  2011-07-30       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.